MINI REVIEW article
Front. Oncol.
Sec. Thoracic Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1687360
This article is part of the Research TopicArtificial Intelligence Advancing Lung Cancer Screening and TreatmentView all articles
AI-based Prediction of Pathological Risk Factors in Lung Adenocarcinoma from CT Imaging: Bridging Innovation and Clinical Practice
Provisionally accepted- 1Huazhong University of Science and Technology Tongji Medical College Union Hospital, Wuhan, China
- 2Sun Yat-Sen University, Guangzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Lung adenocarcinoma (LUAD) is one of the main causes of cancer-related mortality worldwide. Pathological risk factors such as spreading through air spaces, high-risk pathological subtypes, occult lymph nodes, and visceral pleural invasion have significant impact on patient prognosis. In recent years, there has been significant progress in the application of artificial intelligence (AI) technology, e.g., deep learning (DL), in medical image analysis and pathological diagnosis of lung cancer, offering novel approaches for predicting the aforementioned pathological risk factors. This article reviews recent advancements in AI-based analysis and prediction of pathological risk factors in lung adenocarcinoma, with a focus on the applications and limitations of DL models, focusing on studies aimed at improving diagnostic accuracy and efficiency for specific high-risk pathological subtypes. Finally, we summarize current challenges and future directions, emphasizing the need to expand dataset diversity and scale, improve model interpretability, and enhance the clinical applicability of AI models. This article aims to provide a reference for future research on the analysis and prediction of pathological risk factors of LUAD and to promote the development and application of AI, especially DL, in this field.
Keywords: artificial intelligence, Pathology, deep learning, High risk factors, Lung Adenocarcinoma
Received: 17 Aug 2025; Accepted: 17 Oct 2025.
Copyright: © 2025 Huang, Zhao, Yan, Zhang, Geng, Mei, Li and Liao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Kuo Li, lktj126@126.com
Yongde Liao, 2019xh0249@hust.edu.cn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.